ArticleJournal of medical case reports2026
Complete tumor regression with exclusive Ayurvedic treatment in adenocarcinoma of prostate: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProstate cancer is a significant concern for men due to its impact on quality of life and longevity. The global incidence and mortality rates have been on the rise. While traditional treatments are effective, some patients explore complementary therapies like Ayurveda. This article presents a case of prostate cancer showing complete tumor regression with Ayurvedic oral medications. CASE PRESENTATIONS: A 45-year-old male of South Asian ethnicity (Indian origin), born in Kerala and currently residing in the United States, sought a telephonic consultation regarding urinary symptoms persisting for 6 months. The patient reported dysuria, increased urinary frequency, urgency, and a sensation of incomplete voiding. A prostate biopsy mapping revealed a CA lesion measuring 0.06 cm in the right mid-region of the prostate gland, and Gleason score mapped for 6. Based on the UroPredict staging system, as per the National Comprehensive Cancer Network (NCCN) and American Joint Commission on Cancer (AJCC), clinical staging was found to be T1. Ayurvedic interventions were administered to correct the Apana Vayu Vaigunya, and the treatment protocol was based on the Ayurvedic principles of 'Udavartham' and Mutragranthi.
conclusionsAfter 9 months of treatment, a complete regression of the cancer lesions in the right mid region of the prostate gland was observed in the post-biopsy. The patient remains cancer-free after 12 years of treatment. Although Ayurvedic therapy offers a holistic approach, the absence of randomized controlled trials limits the generalizability of our findings and underscores the need for more rigorous scientific validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.